<div><p>Aims</p><p>The matrix metalloproteinase (MMP) 2/9, also known as collagenases IV and gelatinases A/B, play a key role in cancer invasion and metastasis. However, the clinical trials of the MMP inhibitors (MMPIs) ended up with disappointing results. In this paper, we synthesized a gelatinase-responsive copolymer (mPEG-PCL) by inserting a gelatinase cleavable peptide (PVGLIG) between mPEG and PCL blocks of mPEG-PCL for anticancer drug delivery to make use of MMP2/9 as an intelligent target for drug delivery.</p><p>Materials and Methods</p><p>mPEG-pep-PCL copolymer was synthesized via ring-opening copolymerization and double-amidation. To evaluate whether Nanoparticles (NPs) prepared from this copolymer are superior to NPs prepared fro...
Therapeutics such as proteins, small interfering RNA (siRNA) and DNA can only exert their function w...
Targeted therapeutics should accumulate at disease sites in higher quantities relative to other loca...
Here, we have exploited the heightened extracellular concentration of matrix metalloproteinase-9 (MM...
AIMS: The matrix metalloproteinase (MMP) 2/9, also known as collagenases IV and gelatinases A/B, pla...
The matrix metalloproteinase (MMP) 2/9, also known as collagenases IV and gelatinases A/B, play a ke...
Qin Liu1*, Ru-Tian Li1*, Han-Qing Qian2, Mi Yang1, Zhen-Shu Zhu2, Wei Wu2, Xiao-Ping Qian1, Li-Xia Y...
Xiaoyan Zhang, Xiaofei Wang, Weitong Zhong, Xiaoqing Ren, Xianyi Sha, Xiaoling FangKey Laboratory of...
There are several limitations to the application of nanoparticles in the treatment of cancer, includ...
The balance between dose-dependent tolerability, effectiveness and toxicity of systemically administ...
[[abstract]]Systemic adverse effects and poor accumulation at tumor sites constitute important limit...
Nanoparticles (NPs) have been continuously utilized for different implementations, most particularly...
Abstract Matrix metalloproteinase (MMP) 2 and 9 are the family members of proteases normally up-regu...
International audienceIn response to the challenges of cancer chemotherapeutics, including poor phys...
Development of a successful bioresponsive drug delivery system requires exquisite engineering of mat...
Specific cancer cell targeting is a pre-requisite for efficient drug delivery as well as for high-re...
Therapeutics such as proteins, small interfering RNA (siRNA) and DNA can only exert their function w...
Targeted therapeutics should accumulate at disease sites in higher quantities relative to other loca...
Here, we have exploited the heightened extracellular concentration of matrix metalloproteinase-9 (MM...
AIMS: The matrix metalloproteinase (MMP) 2/9, also known as collagenases IV and gelatinases A/B, pla...
The matrix metalloproteinase (MMP) 2/9, also known as collagenases IV and gelatinases A/B, play a ke...
Qin Liu1*, Ru-Tian Li1*, Han-Qing Qian2, Mi Yang1, Zhen-Shu Zhu2, Wei Wu2, Xiao-Ping Qian1, Li-Xia Y...
Xiaoyan Zhang, Xiaofei Wang, Weitong Zhong, Xiaoqing Ren, Xianyi Sha, Xiaoling FangKey Laboratory of...
There are several limitations to the application of nanoparticles in the treatment of cancer, includ...
The balance between dose-dependent tolerability, effectiveness and toxicity of systemically administ...
[[abstract]]Systemic adverse effects and poor accumulation at tumor sites constitute important limit...
Nanoparticles (NPs) have been continuously utilized for different implementations, most particularly...
Abstract Matrix metalloproteinase (MMP) 2 and 9 are the family members of proteases normally up-regu...
International audienceIn response to the challenges of cancer chemotherapeutics, including poor phys...
Development of a successful bioresponsive drug delivery system requires exquisite engineering of mat...
Specific cancer cell targeting is a pre-requisite for efficient drug delivery as well as for high-re...
Therapeutics such as proteins, small interfering RNA (siRNA) and DNA can only exert their function w...
Targeted therapeutics should accumulate at disease sites in higher quantities relative to other loca...
Here, we have exploited the heightened extracellular concentration of matrix metalloproteinase-9 (MM...